These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24860987)

  • 21. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
    Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
    BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy.
    Wikman AT; Tiblad E; Karlsson A; Olsson ML; Westgren M; Reilly M
    Obstet Gynecol; 2012 Aug; 120(2 Pt 1):227-34. PubMed ID: 22776962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD.
    Clausen FB; Jakobsen TR; Rieneck K; Krog GR; Nielsen LK; Tabor A; Dziegiel MH
    PLoS One; 2013; 8(10):e76990. PubMed ID: 24204719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping.
    Stensrud M; Bævre MS; Alm IM; Wong HY; Herud I; Jacobsen B; de Vos DDJA; Stjern HE; Sørvoll IH; Barane JB; Bagås TE; Rasmussen M; Ulvahaug N; Wamstad V; Tomter G; Akkök CA
    Fetal Diagn Ther; 2023; 50(4):276-281. PubMed ID: 37379821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
    Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
    Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care.
    Clausen FB
    Prenat Diagn; 2014 May; 34(5):409-15. PubMed ID: 24431264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive fetal RhD genotyping from maternal blood.
    Kolialexi A; Tounta G; Mavrou A
    Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.
    Blomme S; Nollet F; Rosseel W; Bogaard N; Devos H; Emmerechts J; Cauwelier B
    Transfusion; 2022 May; 62(5):1103-1109. PubMed ID: 35352833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
    Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M
    PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
    Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
    Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population.
    Grande M; Ordoñez E; Cirigliano V; Cid J; Grau E; Pericot A; Teixido I; Marin JL; Borrell A
    Prenat Diagn; 2013 Feb; 33(2):173-8. PubMed ID: 23280558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
    Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
    Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of maternal plasma for noninvasive determination of fetal RhD status.
    Harper TC; Finning KM; Martin P; Moise KJ
    Am J Obstet Gynecol; 2004 Nov; 191(5):1730-2. PubMed ID: 15547554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.